{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:16:48Z","timestamp":1788225408363,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82303251"],"award-info":[{"award-number":["Grant No. 82303251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["Grant No. ZR2023QH202"],"award-info":[{"award-number":["Grant No. ZR2023QH202"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clear cell renal cell carcinoma (ccRCC) exhibits a paradoxical fructose metabolism signature characterized by upregulation of the fructose transporter GLUT5 alongside downregulation of the catabolic enzymes (ketohexokinase, aldolase B, and triokinase), a pattern associated with poor prognosis. Functionally, unlike the pro-survival effect of fructose under glucose deprivation, in the presence of glucose, fructose co-treatment suppresses ccRCC cell proliferation, and induces profound mitochondrial dysfunction, including impaired oxidative phosphorylation, loss of membrane potential, excessive mitochondrial superoxide production, reduced mtDNA copy number, and downregulation of mitochondria-encoded electron transport chain subunits (notably ND2 and ND4 of complex I). Mechanistically, co-treatment with glucose and fructose creates a metabolic trap resulting in fructose-1-phosphate accumulation and ATP depletion. This energy crisis drives profound depletion of purine and pyrimidine nucleotide pools, which selectively triggers the PERK-eIF2S1-ATF4-CHOP axis of the integrated stress response, thereby mediating mitochondrial impairment and ultimately sensitizing ccRCC cells to intrinsic apoptosis via BID cleavage and caspase-3 activation under nutrient stress. Pharmacological treatment with the chemical chaperone 4-phenylbutyric acid (4-PBA) or nucleoside supplementation reverses mitochondrial dysfunction and fructose-induced cytotoxicity. The tumor-suppressive effect of fructose is validated in patient-derived organoids and xenograft mouse models, where fructose administration significantly attenuates tumor growth via ER stress. These findings reveal fructose-driven nucleotide depletion and PERK-dependent ER stress leading to mitochondrial dysfunction, which underlies the tumor-suppressive toxicity of fructose and exposes a targetable metabolic vulnerability in ccRCC.<\/jats:p>","DOI":"10.1038\/s41419-026-09157-3","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:13:40Z","timestamp":1786079620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fructose induces PERK-dependent ER stress and mitochondrial dysfunction via nucleotide depletion in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-3363","authenticated-orcid":false,"given":"Yanhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0852-6280","authenticated-orcid":false,"given":"Bowen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongbin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-1560","authenticated-orcid":false,"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-4486","authenticated-orcid":false,"given":"Shuzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8459-416X","authenticated-orcid":false,"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-5825","authenticated-orcid":false,"given":"Ningning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"9157_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA: A Cancer J Clin"},{"key":"9157_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017;13:410\u20139.","journal-title":"Nat Rev Nephrol"},{"key":"9157_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-nutr-062220-025831","volume":"42","author":"S Jung","year":"2022","unstructured":"Jung S, Bae H, Song WS, Jang C. Dietary fructose and fructose-induced pathologies. Annu Rev Nutr. 2022;42:45\u201366.","journal-title":"Annu Rev Nutr"},{"key":"9157_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cmet.2017.12.016","volume":"27","author":"C Jang","year":"2018","unstructured":"Jang C, Hui S, Lu W, Cowan AJ, Morscher RJ, Lee G, et al. The small intestine converts dietary fructose into glucose and organic acids. Cell Metab. 2018;27:351\u201361.e3.","journal-title":"Cell Metab"},{"key":"9157_CR5","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1002\/j.2040-4603.2022.tb00207.x","volume":"12","author":"V Vallon","year":"2021","unstructured":"Vallon V, Nakagawa T. Renal tubular handling of glucose and fructose in health and disease. Compr Physiol. 2021;12:2995\u20133044.","journal-title":"Compr Physiol"},{"key":"9157_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.123.22535","volume":"81","author":"BR Forester","year":"2024","unstructured":"Forester BR, Zhang R, Schuhler B, Brostek A, Gonzalez-Vicente A, Garvin JL. Knocking out sodium glucose-linked transporter 5 prevents fructose-induced renal oxidative stress and salt-sensitive hypertension. Hypertension (Dallas, Tex : 1979). 2024;81:1296\u2013307.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"9157_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1172\/JCI96702","volume":"128","author":"SA Hannou","year":"2018","unstructured":"Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and metabolic disease. J Clin Investig. 2018;128:545\u201355.","journal-title":"J Clin Investig"},{"key":"9157_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1681\/ASN.2019101015","volume":"31","author":"T Nakagawa","year":"2020","unstructured":"Nakagawa T, Johnson RJ, Andres-Hernando A, Roncal-Jimenez C, Sanchez-Lozada LG, Tolan DR, et al. Fructose production and metabolism in the kidney. J Am Soc Nephrol. 2020;31:898\u2013906.","journal-title":"J Am Soc Nephrol"},{"key":"9157_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2023.02.013","volume":"199","author":"H Guo","year":"2023","unstructured":"Guo H, Fang T, Cheng Y, Li T, Qu JR, Xu CF, et al. ChREBP-\u03b2\/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells. Free Radic Biol Med. 2023;199:154\u201365.","journal-title":"Free Radic Biol Med"},{"key":"9157_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1681\/ASN.2008060576","volume":"20","author":"P Cirillo","year":"2009","unstructured":"Cirillo P, Gersch MS, Mu W, Scherer PM, Kim KM, Gesualdo L, et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol. 2009;20:545\u201353.","journal-title":"J Am Soc Nephrol"},{"key":"9157_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41374-019-0203-3","volume":"99","author":"J Wang","year":"2019","unstructured":"Wang J, Wu Q, Qiu J. Accumulation of fructose 1,6-bisphosphate protects clear cell renal cell carcinoma from oxidative stress. Lab Investig. 2019;99:898\u2013908.","journal-title":"Lab Investig"},{"key":"9157_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2016.09.006","volume":"30","author":"WL Chen","year":"2016","unstructured":"Chen WL, Wang YY, Zhao A, Xia L, Xie G, Su M, et al. Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer cell. 2016;30:779\u201391.","journal-title":"Cancer cell"},{"key":"9157_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cmet.2020.12.005","volume":"33","author":"S Jeong","year":"2021","unstructured":"Jeong S, Savino AM, Chirayil R, Barin E, Cheng Y, Park SM, et al. High fructose drives the serine synthesis pathway in acute myeloid leukemic cells. Cell Metab. 2021;33:145\u201359.e6.","journal-title":"Cell Metab"},{"key":"9157_CR14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.aat8515","volume":"363","author":"MD Goncalves","year":"2019","unstructured":"Goncalves MD, Lu C, Tutnauer J, Hartman TE, Hwang SK, Murphy CJ, et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Sci (N Y, NY). 2019;363:1345\u20139.","journal-title":"Sci (N Y, NY)"},{"key":"9157_CR15","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3804","volume":"5","author":"X Fan","year":"2017","unstructured":"Fan X, Liu H, Liu M, Wang Y, Qiu L, Cui Y. Increased utilization of fructose has a positive effect on the development of breast cancer. PeerJ. 2017;5:e3804.","journal-title":"PeerJ"},{"key":"9157_CR16","doi-asserted-by":"crossref","unstructured":"Chen WL, Jin X, Wang M, Liu D, Luo Q, Tian H, et al. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK\/mTORC1 signaling. JCI insight. 2020;5:e131596.","DOI":"10.1172\/jci.insight.131596"},{"key":"9157_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm7985","volume":"8","author":"SS Tee","year":"2022","unstructured":"Tee SS, Kim N, Cullen Q, Eskandari R, Mamakhanyan A, Srouji RM, et al. Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging. Sci Adv. 2022;8:eabm7985.","journal-title":"Sci Adv"},{"key":"9157_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73653-5","volume":"10","author":"B Dewdney","year":"2020","unstructured":"Dewdney B, Alanazy M, Gillman R, Walker S, Wankell M, Qiao L, et al. The effects of fructose and metabolic inhibition on hepatocellular carcinoma. Sci Rep. 2020;10:16769.","journal-title":"Sci Rep"},{"key":"9157_CR19","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.cmet.2023.09.011","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yu X, Bao R, Huang H, Gu C, Lv Q, et al. Dietary fructose-mediated adipocyte metabolism drives antitumor CD8(+) T cell responses. Cell Metab. 2023;35:2107\u201318.e6.","journal-title":"Cell Metab"},{"key":"9157_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/or.2010.1096","volume":"25","author":"V Medina Villaamil","year":"2011","unstructured":"Medina Villaamil V, Aparicio Gallego G, Valbuena Rubira L, Garc\u00eda Campelo R, Valladares-Ayerbes M, Grande Pulido E, et al. Fructose transporter GLUT5 expression in clear renal cell carcinoma. Oncol Rep. 2011;25:315\u201323.","journal-title":"Oncol Rep"},{"key":"9157_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3892\/mmr_00000300","volume":"3","author":"LM Aparicio","year":"2010","unstructured":"Aparicio LM, Villaamil VM, Calvo MB, Rubira LV, Rois JM, Valladares-Ayerbes M, et al. Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters. Mol Med Rep. 2010;3:575\u201380.","journal-title":"Mol Med Rep"},{"key":"9157_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10565-019-09478-4","volume":"35","author":"X Jin","year":"2019","unstructured":"Jin X, Liang Y, Liu D, Luo Q, Cai L, Wu J, et al. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma. Cell Biol Toxicol. 2019;35:471\u201383.","journal-title":"Cell Biol Toxicol"},{"key":"9157_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s12672-025-02688-9","volume":"16","author":"J Miao","year":"2025","unstructured":"Miao J, Wang D, Pang R, Zhang H, Wu Y, Sun X, et al. Role of fructose in renal cell carcinoma progression. Discov Oncol. 2025;16:897.","journal-title":"Discov Oncol"},{"key":"9157_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/pmic.200401345","volume":"6","author":"JS Hwa","year":"2006","unstructured":"Hwa JS, Kim HJ, Goo BM, Park HJ, Kim CW, Chung KH, et al. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. Proteomics. 2006;6:1077\u201384.","journal-title":"Proteomics"},{"key":"9157_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.161.3847.1253","volume":"161","author":"PH M\u00e4enp\u00e4\u00e4","year":"1968","unstructured":"M\u00e4enp\u00e4\u00e4 PH, Raivio KO, Kekom\u00e4ki MP. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Sci (N Y, NY). 1968;161:1253\u20134.","journal-title":"Sci (N Y, NY)"},{"key":"9157_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.0022-3042.2002.00744.x","volume":"80","author":"Y Liu","year":"2002","unstructured":"Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem. 2002;80:780\u20137.","journal-title":"J Neurochem"},{"key":"9157_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491\u2013501.","journal-title":"Cell"},{"key":"9157_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19263-1","volume":"11","author":"J Kim","year":"2020","unstructured":"Kim J, Kang J, Kang YL, Woo J, Kim Y, Huh J, et al. Ketohexokinase-A acts as a nuclear protein kinase that mediates fructose-induced metastasis in breast cancer. Nat Commun. 2020;11:5436.","journal-title":"Nat Commun"},{"key":"9157_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.bbrc.2018.07.040","volume":"503","author":"W Gao","year":"2018","unstructured":"Gao W, Li N, Li Z, Xu J, Su C. Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma. Biochem Biophys Res Commun. 2018;503:1298\u2013306.","journal-title":"Biochem Biophys Res Commun"},{"key":"9157_CR30","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.cmet.2018.04.003","volume":"27","author":"P Bu","year":"2018","unstructured":"Bu P, Chen KY, Xiang K, Johnson C, Crown SB, Rakhilin N, et al. Aldolase B-mediated fructose metabolism drives metabolic reprogramming of colon cancer liver metastasis. Cell Metab. 2018;27:1249\u201362.e4.","journal-title":"Cell Metab"},{"key":"9157_CR31","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res : J Am Assoc Cancer Res. 2018;24:2482\u201390.","journal-title":"Clin Cancer Res : J Am Assoc Cancer Res"},{"key":"9157_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17:351\u20139.","journal-title":"Nat Cell Biol"},{"key":"9157_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1196\/annals.1427.015","volume":"1147","author":"AA Starkov","year":"2008","unstructured":"Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci. 2008;1147:37\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"9157_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol cell Biol. 2020;21:85\u2013100.","journal-title":"Nat Rev Mol cell Biol"},{"key":"9157_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrm.2015.8","volume":"17","author":"MJ Phillips","year":"2016","unstructured":"Phillips MJ, Voeltz GK. Structure and function of ER membrane contact sites with other organelles. Nat Rev Mol cell Biol. 2016;17:69\u201382.","journal-title":"Nat Rev Mol cell Biol"},{"key":"9157_CR36","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1089\/ars.2007.1782","volume":"9","author":"JD Malhotra","year":"2007","unstructured":"Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277\u201393.","journal-title":"Antioxid Redox Signal"},{"key":"9157_CR37","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.cmet.2021.09.010","volume":"33","author":"MA Herman","year":"2021","unstructured":"Herman MA, Birnbaum MJ. Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 2021;33:2329\u201354.","journal-title":"Cell Metab"},{"key":"9157_CR38","doi-asserted-by":"crossref","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22:9221.","DOI":"10.3390\/ijms22179221"},{"key":"9157_CR39","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.2337\/db12-1814","volume":"62","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62:3307\u201315.","journal-title":"Diabetes"},{"key":"9157_CR40","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/ACI.0b013e3280109b57","volume":"6","author":"SL Masters","year":"2006","unstructured":"Masters SL, Lobito AA, Chae J, Kastner DL. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol. 2006;6:428\u201333.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9157_CR41","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s42255-025-01368-w","volume":"7","author":"T Feng","year":"2025","unstructured":"Feng T, Luo Q, Liu Y, Jin Z, Skwarchuk D, Lee R, et al. Fructose and glucose from sugary drinks enhance colorectal cancer metastasis via SORD. Nat Metab. 2025;7:2018\u201332.","journal-title":"Nat Metab"},{"key":"9157_CR42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813\u201320.","journal-title":"Nature"},{"key":"9157_CR43","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1080\/15548627.2015.1017185","volume":"11","author":"X Zhao","year":"2015","unstructured":"Zhao X, Fang Y, Yang Y, Qin Y, Wu P, Wang T, et al. Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells. Autophagy. 2015;11:1849\u201363.","journal-title":"Autophagy"},{"key":"9157_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","volume":"10","author":"X Li","year":"2018","unstructured":"Li X, Cui XX, Chen YJ, Wu TT, Xu H, Yin H, et al. Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson\u2019s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function. Front Aging Neurosci. 2018;10:121.","journal-title":"Front Aging Neurosci"},{"key":"9157_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2011.06.067","volume":"412","author":"AN Malik","year":"2011","unstructured":"Malik AN, Shahni R, Rodriguez-de-Ledesma A, Laftah A, Cunningham P. Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias. Biochem Biophys Res Commun. 2011;412:1\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"9157_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101495","volume":"32","author":"N Wang","year":"2020","unstructured":"Wang N, Liu H, Liu G, Li M, He X, Yin C, et al. Yeast \u03b2-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis. Redox Biol. 2020;32:101495.","journal-title":"Redox Biol"},{"key":"9157_CR47","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1172\/JCI94427","volume":"128","author":"MA Lanaspa","year":"2018","unstructured":"Lanaspa MA, Andres-Hernando A, Orlicky DJ, Cicerchi C, Jang C, Li N, et al. Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice. J Clin Investig. 2018;128:2226\u201338.","journal-title":"J Clin Investig"},{"key":"9157_CR48","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1128\/AEM.01178-10","volume":"76","author":"VA Portnoy","year":"2010","unstructured":"Portnoy VA, Scott DA, Lewis NE, Tarasova Y, Osterman AL, Palsson B. Deletion of genes encoding cytochrome oxidases and quinol monooxygenase blocks the aerobic-anaerobic shift in Escherichia coli K-12 MG1655. Appl Environ Microbiol. 2010;76:6529\u201340.","journal-title":"Appl Environ Microbiol"},{"key":"9157_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2020.07.018","volume":"32","author":"L Liu","year":"2020","unstructured":"Liu L, Li T, Liao Y, Wang Y, Gao Y, Hu H, et al. Triose kinase controls the lipogenic potential of fructose and dietary tolerance. Cell Metab. 2020;32:605\u201318.e7.","journal-title":"Cell Metab"},{"key":"9157_CR50","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang X, Wang N, Jiang H, Liang N, Du C, et al. Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis. Signal Transduction Targeted Therapy. 2026;11:195.","DOI":"10.1038\/s41392-026-02695-4"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09157-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:04:06Z","timestamp":1788224646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09157-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9157"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09157-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Experiments involving clinical samples were approved by the Research Ethics Committee of WeiFang People\u2019s Hospital (Approval No. KYLL20221214-3). All samples were obtained from patients who provided written informed consent for the use of their tissues and clinical data. Animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee of the Medical Laboratory Animal Center at Shandong Second Medical University (IACUC Approval No. 2025SDL626). All methods involving clinical samples and animal experiments were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"766"}}